CLINICAL_TRIALS trial_result · 2022-01-21

Clinical Trial Update: Study of Azeliragon in Patients With Mild Alzheimer's Disease and Impaired Glucose Tolerance [Phase 2]

Phase 2 trial of azeliragon in mild Alzheimer's disease with impaired glucose tolerance was terminated; results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: vTv Therapeutics | Conditions: Alzheimer Disease | Phase 2 | Status: TERMINATED | Results posted: 2022-01-21